Abstract
Anxiolytic drugs, also called “minor tranquillizers” or anti-anxiety drugs, are substances which reduce pathological anxiety, tension and agitation without therapeutic effects on cognitive or perceptual processes. Most of these drugs are also potent anticonvulsants, sedatives and hypnotics. Several classes (groups) of drugs possess anxiolytic properties. The most important group is the benzodiazepines, which are remarkably non-toxic, much less toxic than the barbiturates. Meprobamate is an anxiolytic drug much used in the 1950s and 1960s but without a known mechanism of action at the biochemical or synaptic level (Berger, 1975). Miscellaneous drugs, such as ß-blockers, and some neuroleptic and antidepressant drugs possess anxiolytic properties in some clinical situations, but are not considered true anxiolytic drugs. The present chapter will focus on the benzodiazepines and emphasis will be given to biochemical effects pertinent to their mechanism of action.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arnt, J., Scheel-Krüger, J.: GABA-ergic and glycinergic mechanisms within the Substantia Nigra. Pharmacological specificity of dopamine dependent counterlateral turning behavior and interaction with other neurotransmitters. Psychopharmacology 62, 267–277 (1979)
Bartholini, G., Keller, H., Pieri, L., Pletscher, A.: Diazepam and cerebral dopamine. In: The benzodiazepines. Garattini, S., Mussini, E., Randall, L.O. (eds.), pp. 235–240. New York: Raven 1973
Beaumont, K., Chilton, W., Yamamura, H.I., Enna, S.J.: Muscimol binding in rat brain: Association with synaptic GABA receptors. Brain Res. 148, 153–162 (1978)
Beer, B., Chasin, M., Clody, D.E., Vogel, J.R., Horovitz, Z.P.: Cyclic adenosine monophosphate phosphodiesterase in brain: Effect on anxiety. Science 176, 428–430 (1972)
Bennett, J.P., Snyder, S.H.: Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors. Brain Res. 94, 523–544 (1975)
Berger, F.M.: The pharmacology of antianxiety (anxiolytic) agents. In: Psychopharmacological treatment. Denber, H.C.B. (ed.), pp. 135–156. New York: Dekker 1975
Bernasconi, R., Martin, P.: Effects of diazepam and baclofen on the GABA turnover rate in various mouse brain regions. Arch. Pharmacol. [Suppl.] 302, R58 (1978)
Biggio, G., Casu, M., Corda, M.G., Vernaleone, F., Gessa, G.L.: Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain. Life Sci. 21, 525–532 (1977 a)
Biggio, G., Guidotti, A.; Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism. Nature 265, 240–242 (1977)
Biggio, G., Brodie, B.B., Costa, E., Guidotti, A.: Mechanisms by which diazepam muscimol, and other drugs change the content of cGMP in cerebellar cortex. Proc. Natl. Acad. Sci. USA 74, 3592–3596 (1977 b)
Biggio, G., Corda, M.G., Casu, M., Gessa, G.L.: Kainic acid-induced lesion of dopaminergic target cells in the striatum: Consequences on the dynamics of cerebellar cGMP. Naunyn-Schmiedebergs Arch. Pharmacol. 304, 5–7 (1978)
Billingsley, M.L., Kubena, R.K.: The effects of naloxone and Picrotoxin on the sedative and anticonflict effects of benzodiazepines. Life Sci. 22, 897–906 (1978)
Biswas, B., Carlsson, A.: On the mode of action of diazepam on brain catecholamine metabolism. Naunyn Schmiedebergs Arch. Pharmacol. 303, 73–78 (1978)
Blanchard, J.C., Boireau, A., Jolon, L.: In Vitro and in Vivo Inhibition by zopiclone of benzodiazepine binding to rodent brain receptors. Life Sci. 24, 2417–2420 (1979)
Boakes, R.J., Martin, I.L., Mitchell, P.R.: Burst firing of cerebellar Purkinje neurones induced by benzodiazepines. Neuropharmacology 16, 711–713 (1977)
Bolme, P., Fuxe, K.: Possible involvement of GABA mechanisms in central cardiovascular and respiratory control. Studies on the interaction between diazepam, picrotoxin and Clonidine. Med. Biol. 55, 301–309 (1977)
Bosmann, H.B., Case, K.R., DiStefano, P.: Diazepam receptor characterization: specific binding of a benzodiazepine to macromolecules in various areas of rat brain. FEBS Lett. 82, 368–372 (1977)
Bosmann, H.B., Penney, D.P., Case, K.R., DiStefano, P., Averill, K.: Diazepam receptor: specific binding of [3H]diazepam and [3H]flunitrazepam to rat brain subfractions. FEBS Lett. 87, 199–202 (1978)
Bourgoin, S., Héry, F., Ternaux, J.P., Hamon, M.: Effects of benzodiazepines on the binding of tryptophan in serum. Consequences on 5-hydroxyindoles concentrations in the rat brain. Psychopharmacol. Commun. 1, 209–216 (1975)
Bowery, N.G., Dray, A.: Barbiturate reversal of amino acid antagonism produced by consul-sant agents. Nature 264, 276–278 (1976)
Bowery, N.G., Dray, A.: Reversal of the action of amino acid antagonists by barbiturates and other hypnotic drugs. Br. J. Pharmacol. 63, 197–215 (1978)
Braestrup, C., Squires, R.F.: Specific benzodiazepine receptor in rat brain characterized by high-affinity 3H-diazepam binding. Proc. Natl. Acad. Sci. USA 74, 3805–3809 (1977)
Braestrup, C., Albrechtsen, R., Squires, R.F.: High densities of benzodiazepine receptors in human cortical areas. Nature 269, 702–704 (1977)
Braestrup, C., Squires, R.F.: Pharmacological characterization of benzodiazepine receptors in the brain. Eur. J. Pharmacol. 78, 263–270 (1978 a)
Braestrup, C., Squires, R.F.: Brain specific benzodiazepine receptors. Br. J. Psychiatry 133, 249–260 (1978 b)
Braestrup, C., Squires, R.F., Bock, E., Torp Pedersen, C., Nielsen, M.: Benzodiazepine receptors: Cellular and subcellular localization in brain. Adv. Pharm. Ther. 7, 173–185 (1978 a)
Braestrup, C., Nissen, C., Squires, R.F., Schousboe, A.: Lack of brain-specific benzodiazepine receptors on mouse primary astroglial cultures, which specifically bind haloperidol. Neurosci. Lett. 9, 45–49 (1978 b)
Braestrup, C., Nielsen, M.: Ontogenetic development of benzodiazepine receptors in the rat brain. Brain Res. 147, 170–173 (1978)
Braestrup, C., Nielsen, M., Squires, R.F.: No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam. Life Sci. 24, 347–350 (1979 a)
Braestrup, C., Nielsen, M., Squires, R.F.: Neuronal localization of benzodiazepine receptors in cerebellum. Neurosci. Lett. 13, 219–224, (1979 b)
Braestrup, C., Nielsen, M., Nielsen, E.B., Lyon, M.: Benzodiazepine receptors in brain are affected by several different experimental stresses, the changes are small and not unidirectional. Psychopharmacologia, 65, 273–277 (1979 c)
Braestrup, C., Nielsen, M., Krogsgaard-Larsen, P., Falch, E.: Partial agonists for brain GABA/benzodiazepine receptor complex. Nature 280, 331–333 (1979 d)
Braestrup, C., Nielsen, M., Olsen, C-E.: Urinary and brain ß-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc. Natl. Acad. Sci. USA 77, 2288–2292 (1980)
Briley, M.S., Langer, S.Z.: Influence of GABA receptor agonists and antagonist on the binding of 3H-diazepam to the benzodiazepine receptor. Eur. J. Pharmacol. 52, 129–132 (1978)
Brodersen, R., Sjödin, T., Sjöholm, I.: Independent binding of ligands to human serum albumin. J. Biol. Chem. 252, 5067–5072 (1977)
Brown, D.A., Constanti, A.: Interaction of pentobarbitone and γ-aminobutyric acid on mammalian sympathetic ganglion cells. Br. J. Pharmacol. 63, 217–224 (1978)
Burt, D.R., Creese, I., Snyder, S.H.: Properties of [3H] haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. Mol. Pharmacol. 12,800–812 (1976)
Bylund, D., Snyder, S.H.: Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol. Pharmacol. 12, 568–580 (1976)
Chang, R.S.L., Snyder, S.H.: Benzodiazepine receptors: Labeling in intact animals with [3H]flunitrazepam. Eur. J. Pharmacol. 48, 213–218 (1978)
Chase, T.N., Katz, R.I., Kopin, I.J.: Effect of diazepam on fate of intracisternally injected serotonin-C14. Neuropharmacology 9, 103–108 (1970)
Chéramy, A., Nieoullon, A., Glowinski, J.: Blockade of the picrotoxin-induced in vivo release of dopamine in the cat caudate nucleus by diazepam. Life Sci. 20, 811–816 (1977)
Chéramy, A., Nieoullon, A., Glowinski, J.: Gabaergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat. Eur. J. Pharmacol. 48, 281–295 (1978)
Chieu, T.H., Rosenberg, H.C.: Reduced diazepam binding following chronic benzodiazepine treatment. Life Sci. 23, 1153–1158 (1978)
Chieu, T.H., Rosenberg, H.C.: GABA receptor-mediated modulation of 3H-diazepam binding in rat cortex. Eur. J. Pharmacol. 56, 337–345 (1979)
Choi, D.W., Farb, D.H., Fischbach, G.D.: Chlordiazepoxide selectively augments GABA action in spinal cord cell cultures. Nature 269, 342–344 (1977)
Consolo, S., Ladinsky, H., Peri, G., Garattini, S.: Effect of central stimulants and depressant on mouse brain acetylcholine and choline levels. Eur. J. Pharmacol. 18, 251–255 (1972)
Consolo, S., Ladinsky, H., Peri, G., Garattini, S.: Effect of diazepam on mouse whole brain and brain area acetylcholine and choline levels. Eur. J. Pharmacol. 27, 266–268 (1974)
Consolo, S., Garattini, S., Ladinsky, H.: Action of the benzodiazepines on the cholinergic system. In: Mechanism of action of benzodiazepines. Costa, E., Greengard, P. (eds.), pp. 63–80. New York: Raven 1975
Consolo, S., Ladinsky, H., Bianchi, S., Ghezzi, D.: Apparent lack of a dopaminergic-cholinergic link in the rat nucleus accumbens septi-tuberculum olfactorium. Brain Res. 135, 255–263 (1977)
Cook, L., Sepinwall, J.: Behavioral analysis of the effects and mechanisms of action of benzodiazepines. In: Mechanism of action of benzodiazepines. Costa, E., Greengard, P. (eds.), pp. 1–28. New York: Raven 1975
Cook, L., Sepinwall, J.: Relationship of anticonflict activity of benzodiazepines to brain receptor binding, serotonin, and GABA. ACNP December 1978
Cooper, B., Handin, R.I., Young, L.H., Alexander, R.W.: Agonist regulation of the human platelet α-adrenergic receptor. Nature 274, 703–706 (1978)
Corrodi, H., Fuxe, K., Lidbrink, P., Olson, L.: Minor tranquillizers, stress and central catecholamine neurons. Brain Res. 29, 1–16 (1971)
Costa, E., Guidotti, A., Mao, C.C., Suria, A.: New concepts on the mechanism of action of benzodiazepines. Life Sci. 17, 167–186 (1975 a)
Costa, E., Guidotti, A., Mao, C.C.: Diazepam, cyclic nucleotides and amino acid neurotransmitters in rat cerebellum. In: Neuropsychopharmacology. Boissier, J.R., Hippius, H., Pichot, P. (eds.), pp. 849–856. Amsterdam: Excerpta Medica 1975 b
Costa, E., Guidotti, A., Mao, C.C.: Evidence for involvement of GABA in the action of benzodiazepines. In: Mechanism of action of benzodiazepines. Costa, E., Greengard, P. (eds.), pp. 113–130. New York: Raven 1975c
Costa, E., Guidotti, A., Toffano, G.: Molecular mechanisms mediating the action of diazepam on GABA receptors. Br. J. Psychiatry. 133, 239–248 (1978)
Costa, T., Rodbard, D., Pert, C.B.: The benzodiazepine receptor coupled to a chloride anionic channel. Nature 277, 315–317 (1979)
Curtis, D.R., Lodge, D., Johnston, G.A.R., Brand, S.J.: Central actions of benzodiazepines. Brain Res. 118, 344–347 (1976 a)
Curtis, D.R., Game, C.J.A., Lodge, D.: Benzodiazepines and central glycine receptors. Br. J. Pharmacol. 56, 307–311 (1976 b)
Curtis, D.R., Lodge, D.: Pentobarbitone enhancement of the inhibitory action of GABA. Nature 270, 543–544 (1977 a)
Curtis, D.R., Lodge, D.: Effect of pentobarbitone on the inhibition of spinal interneurones, in the cat by glycine and GABA. J. Physiol. (Lond.) 272, 48P–49P (1977 b)
DaPrada, M., Pletscher, A.: On the mechanism of chlorpromazine-induced changes of cerebral homovanillic acid levels. J. Pharm. Pharmacol. 18, 628–630 (1966)
Davidoff, R.A.: Diphenylhydantoin increases spinal presynaptic inhibition. Trans. Am. Neurol. Assoc. 97, 193–196 (1972)
Davies, J., Polc, P.: Effect of a water soluble benzodiazepine on the responses of spinal neurones to acetylcholine and excitatory amino acid analogues. Neuropharmacology 17, 217–220 (1978)
DeBlas, A., Mahler, H.R.: Studies on nicotinic acetylcholine receptors in mammalian brain. Characterization of a microsomal subfraction enriched in receptor function for different neurotransmitters. J. Neurochem. 30, 563–577 (1978)
Deisz, R.A., Lux, H.D.: Diphenylhydantoin prolongs postsynaptic inhibition and ionto-phoretic GABA action in the crayfish stretch receptor. Neurosci. Lett. 5, 199–203 (1977)
Dominic, J.A., Sinha, A.K., Barchas, J.D.: Effect of benzodiazepine compounds on brain amine metabolism. Eur. J. Pharmacol. 32, 124–127 (1975)
Domino, E.F., Wilson, A.E.: Psychotropic drug influcences on brain acetylcholine utilization. Psychopharmacology 25, 291–298 (1972)
Doteuchi, M., Costa, E.: Pentylenetetrazol convulsions and brain catecholamine turnover rate in rats and mice receiving diphenylhydantoin or benzodiazepines. Neuropharmacology 12, 1059–1072 (1973)
Dray, A., Straughan, D.W.: Benzodiazepines: GABA and glycine receptors on single neurons in the rat medulla. J. Pharm. Pharmacol. 28, 314–315 (1976)
Eccles, J.C., Schmidt, R., Willis, W.D.: Pharmacological studies on presynaptic inhibition. J. Physiol. (Lond.) 168, 500–530 (1963)
Evans, R.H.: GABA-potentiating action of pentobarbitone on the isolated superior cervical ganglion of the rat. J. Physiol. (Lond.) 272, 49P-50P (1977)
Fennessy, M.R., Lee, J.R.: The effect of benzodiazepines on brain amines of the mouse. Arch. Int. Pharmacodyn. Ther. 197, 37–44 (1972)
Fernholm, B., Nielsen, M., Braestrup, C.,: Absence of brain specific benzodiazepine receptors in cyclostomes and elasmobranchs. Comp. Biochem. Pysiol. 62C, 209–211 (1979)
Fernstrom, J.D., Shabshelowitz, H., Faller, D.V.: Diazepam increases 5-hydroxyindole concentrations in rat brain and spinal cord. Life Sci. 15, 1577–1584 (1974)
File, S.E., Hyde, J.R.G.: The effects of p-chlorophenylalanine and ethanolamine O-sulphate in an animal test of anxiety. J. Pharm. Pharmacol. 29, 735–738 (1977)
File, S.E., Velucci, S.V.: Studies on the role of ACTH and of 5-HT in anxiety using an animal model. J. Pharm. Pharmacol. 30, 105–110 (1978)
Fuxe, K., Agnati, L.F., Bolme, P., Hökfelt, T., Lidbrink, P., Ljungdahl, A, Mora, P. de la, Ögren, S.V.: The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons. In: Mechanism of action of benzodiazepines. Costa, E., Greengard, P. (eds.), pp. 45–61. New York: Raven 1975
Gähwiler, B.H.: Diazepam and chlordiazepoxide: powerful GABA antagonists in expiants of rat cerebellum. Brain Res. 107, 176–179 (1976)
Gale, K., Costa, E., Toffano, G., Hong, J.-S., Guidotti, A.: Evidence for a role of nigral γ-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 206, 29–37 (1978)
Gallager, D.W.: Benzodiazepines: Potentiation of a GABA inhibitory response in the dorsal raphe nucleus. Eur. J. Pharmacol. 49, 133–143 (1978)
Gallager, D.W., Thomas, J.W., Tallman, F.: Effect of GABAergic drugs on benzodiazepine binding site sensitivity in rat cerebral cortex. Biochem. Pharmac. 27, 2745–2749 (1978)
Gey, K.F.: Effect of benzodiazepines on carbohydrate metabolism in rat brain. In: The Benzodiazepines. Garattini, S., Mussini, E., Randall, L.O. (eds.), pp. 243–255. New York: Raven 1973
Giarman, N.J., Pepeu, G.: Drug-induced changes in brain acetylcholine. Br. J. Pharmacol. 19, 226–234 (1962)
Govoni, S., Fresia, P., Spano, P.F., Trabucchi, M.: Effect of desmethyldiazepam and chlordes-methyldiazepam on 3′,5′-cyclic guanosine monophosphate levels in rat cerebellum. Psycho-pharmacology 50, 241–244 (1976)
Guidotti, A.: Synaptic mechanisms in the action of benzodiazepines. In: Psychopharmacology: A Generation of Progress. Lipton, M.A., DiMascio, A., Killam, K.F. (eds.), pp. 1349–1357. New York: Raven 1978
Guidotti, A., Toffano, G., Costa, E.: An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain. Nature 275, 553–555 (1978 a)
Guidotti, A., Toffano, G., Costa, E.: A molecular mechanism for the action of benzodiazepines on GABA receptors. In: GABA-Neurotransmitters. Krogsgaard-Larsen, P., Scheel-Krü-ger, J., Kofod, H. (eds.), pp. 406–419, Copenhagen: Munksgaard 1978 b
Haefely, W., Kulcsár, Möhler, Pieri, L., Polc, P., Schaffner, R.: Possible involvement of GABA in the central actions of benzodiazepines. In: Mechanism of action of benzodiazepines. Costa, E., Greengard, P. (eds.), pp. 131–151. New York: Raven 1975
Haefely, W., Polc, P., Schaffner, R., Keller, H.H., Pieri, I., Möhler, H.: Facilitation of GABAergic transmission by drugs. In: GABA-Neutrotransmitters. The Alfred Benzon Symposium. Krogsgaard-Larsen, P., Scheel-Krü-ger, J., Kofod, H. (eds.), pp. 357–375. Copenhagen: Munksgaard 1978
Harris, M., Hopkin, J. M., Neal, M.J.: Effect of centrally acting drugs on the uptake of γ-aminobutyric acid (GABA) by slices of rat cerebral cortex. Br. J. Pharmacol. 47, 229–239 (1973)
Henn, F.A., Henke, D.J., Cellular localization of [3H]-diazepam receptors. Neuropharmacology 17, 985–988 (1978)
Horovitz, Z.P., Beer, B., Clody, D.E., Vogel, J.R., Chasin, M.: Cyclic AMP and anxiety. Psy-chosomatics 13, 85–92 (1972)
Hunt, P., Raynaud, J.-P.: Benzodiazepine activity: is interaction with the glycine receptor, as evidenced by displacement of strychnine binding, a useful criterion? J. Pharm. Pharmacol. 29, 442–444 (1979)
Iversen, L.L., Johnston, G.A.R.: GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors. J. Neurochem. 18, 1939–1950 (1971)
Jenner, P., Chadwick, D., Reynolds, E.H., Marsden, C.D.: Altered 5-HT metabolism with clonazepam, diazepam and dipenylhydantoin. J. Pharm. Pharmacol. 27, 707–710 (1975)
Juhasz, L., Dairman, W.: Effect of sub-acute diazepam administration in mice on the subsequence ability of diazepam to protect against metrazol and bicuculline induced convulsions. Fed. Proc. 36, 377 (1977)
Karasawa, T., Furukawa, K., Ochi, Y., Shimizu, M.: Monoamine metabolites as indicators of the effect of centrally acting drugs on monoamine release in rat brain. Arch. int. Pharma-codyn. 231, 261–273 (1978)
Karobath, M., Lippitsch, M.: THIP and isoguvacine are partial agonists of GABA-stimulated benzodiazepine receptor binding. Eur. J. Pharmacol. 58, 485–488 (1979)
Karobath, M., Sperk, G.: Stimulation of benzodiazepine receptor binding by y-aminobutyric acid. Proc. Natl. Acad. Sci. USA 76, 1004–1006 (1979)
Karobath, M., Placheta, P., Lippitsch, M., Krogsgaard-Larsen, P.: Is stimulation of benzodiazepine receptor binding mediated by a novel GABA receptor? Nature 278, 748–749 (1979)
Keller, H.H., Schaffner, R., Haefely, W.: Interaction of benzodiazepines with neuroleptics at central dopamine neurons. Naunyn-Schmiedebergs Arch. Pharmacol. 294, 1–7 (1976)
Kozhechkin, S.N., Ostrovskaya, R.U.: Are benzodiazepines GABA antagonists? Nature 269, 72–73 (1977)
Ladinsky, H., Consolo, S., Peri, G., Garattini, S.: Increase in mouse and rat brain acetylcholine levels by diazepam. In: The Benzodiazepines. S. Garattini, E. Mussini, Randall, L.O. (eds.), pp. 241–242. New York: Raven Press 1973
Ladinsky, H., Consolo, S., Bellantuono, C, Garattini, S.: Interaction of benzodiazepines and chemical mediators in the brain. To be published in Handbook of Biological Psychiatry, Rafaelsen and Lader (eds.) New York: Marcel Dekker, Inc. 1979 (in press).
Lidbrink, P., Corrodi, H., Fuxe, K., Olson, L.: Barbiturates and meprobamate: decreases in catecholamine turnover of central dopamine and noradrenaline neuronal systems and the influcence of immobilization stress. Brain Res. 45, 507–524 (1972)
Lidbrink, P., Corrodi, H., Fuxe, K., Olson, L.: The effects of benzodiazepines meprobamate, and barbiturates on central monoamine neurons: In: The Benzodiazepines, pp. 203–220. Garattini, S., Mussini, E., Randall, L.O. (eds.). New York: Raven Press 1973
Lidbrink, P., Corrodi, H., Fuxe, K.: Benzodiazepines and barbiturates: Turnover changes in central 5-hydroxytryptamine pathways. Eur. J. Pharmacol. 26, 35–40 (1974)
Lingjaerde, O.: Effect of benzodiazepines on uptake and efflux of serotonin in human blood patelets in vitro. In: The benzodiazepines. Garattini, S., Mussini, E., Randall, L.O. (eds.), pp. 225–233. New York: Raven 1973
Lippa, A.S., Regan, B.: Additional studies on the importance of glycine and GABA in mediating the actions of benzodiazepines. Life Sci. 21, 1779–1784 (1977)
Lippa, A.S., Critchett, D., Sano, M.C., Kiepner, C.A., Greenblatt, E.N., Coupet, J., Beer, B.: Benzodiazepine Receptors: Cellular and Behavioral Characteristics. Pharmacol. Biochem. Behav. 10, 831–843 (1979)
Lippa, A.S., Sano, M.C., Coupet, J., Beer, B.: Evidence that benzodiazepine receptors reside on cerebellar purkinje cells: Studies with “nervous” mutant mice. Life Sci. 23, 2213–2218 (1978)
Löscher, W., Frey, H.-H.: Effect of convulsant and anticonvulsant agents on level and metabolism of y-aminobutyric acid in mouse brain. Naunyn-Schmiedebergs Arch. Pharmacol. 296, 263–269 (1977)
Lundy, P.M., Magor, G.F.: Cyclic GMP concentrations in cerebellum following organophos-phate administration. J. Pharm. Pharmacol. 30, 251–252 (1978)
MacDonald, R., Barker, J.L.: Benzodiazepines specifically modulate GABA-mediated postsynaptic inhibition in cultured mammalian neurones. Nature 277, 563–564 (1978)
Mackerer, C.R., Kochman, R.L.: Effects of cations and anions on the binding of [3H]-diazepam to rat brain. Proc. Soc. Exp. Biol. Med. 158, 393–397 (1978)
Mackerer, C.R., Kochman, R.L., Bierschenk, A., Bremner, S.S.: The binding of [3H] diazepam to rat brain. J. Pharmacol. Exp. Ther. 206, 405–413 (1978)
Mailman, R.B., Frye, G.D., Mueller, R.A., Breese, G.R.: Thyrotropin-releasing hormone reversal of ethanol-induced decrease in cerebellar cGMP. Nature 272, 832–833 (1978)
Maisov, N.I., Tolmacheva, N.S., Raevsky, K.S.: Liberation of 3H-gamma-aminobutyric acid (3H-GABA) from isolated nerve endings of the rat’s brain under the effect of psychotropic substances (in Russian). Farmakol. Toksikol. 39, 517–520 (1976)
Mao, C.C., Guidotti, A., Costa, E.: The regulation of cyclic guanosine monophosphate in rat cerebellum: possible involvement of putative amino acid neurotransmitters. Brain Res. 79, 510–514 (1974a)
Mao, C.C., Guidotti, A., Costa, E.: Interactions between y-aminobutyric acid and guanosine cyclic 3′,5′-monophosphate in rat cerebellum. Mol. Pharmacol. 10, 736–745 (1974b)
Mao, C.C., Guidotti, A., Costa,: Inhibition by diazepam of the tremor and the increase of cerebellar cGMP content elicited by harmaline. Brain Res. 83, 516–519 (1975 a)
Mao, C.C., Guidotti, A., Costa, E.: Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action of diazepam. Naunyn-Schmiedebergs Arch. Pharmacol. 289, 369–378 (1975 b)
Mao, C.C., Marco, E., Revuelta, A., Bertilsson, L., Costa, E.: The turnover rate of y-amino-butyric acid in the nuclei of telencephalon: Implications in the pharmacology of antipsychotics and of a minor tranquilizer. Biol. Psychiatry 12, 359–371 (1977)
Martin, I.L., Candy, J.M.: Facilitation of benzodiazepine binding by sodium chloride and GABA. Neuropharmacology 17, 993–998 (1978)
Maruyama, S., Kawasaki, T.: Further electrophysiological evidence of the GABA-like effect of droperidol in the purkinje cells of the cat cerebellum. Jpn. J. Pharmacol. 26, 765–767 (1976)
Mattsson, H., Brandt, K., Heilbronn, E.. Bicyclic phosphorus esters increase the cyclic GMP level in rat cerebellum. Nature 268, 52–53 (1977)
Maurer, R.: The GABA agonist THIP, a muscimol analogue, does not interfere with the benzodiazepine binding site on rats cortical membranes. Neurosci. Lett. 12, 65–68 (1979)
Mitchell, P.R., Martin, I.L.: The effects of benzodiazepines of K+-stimulated release of GABA. — Neuropharmacology 17, 317–320 (1978)
Miyahara, J.T., Esplin, D.W., Zablocka, B.: Differential effects of depressant drugs on presynaptic inhibition. J. Pharmacol. Exp. Ther. 154, 119–127 (1966)
Mori, A., Ohkusu, H., Kohsaka, M., Kurono, M.: Isolation of hypoxanthine from calf brain. J. Neurochem. 20, 1291–1292 (1973)
Möhler, H., Okada, T.: Properties of 3H-diazepam binding to benzodiazepine receptors in the rat cerebral cortex. Life Sci. 20, 2101 (1977 a)
Möhler, A., Okada, T.: Benzodiazepine receptor: Demonstration in the central nervous system. Science 198, 848–851 (1977b)
Möhler, A., Okada, T.: GABA receptor binding with 3H(+) bicuculline-methiodide in rat CNS. Nature 267, 65–67 (1977 c)
Möhler, H., Okada, T.: The benzodiazepine receptor in normal and pathological human brain. Br. J. Psychiatry 133, 261–268 (1978)
Möhler, H., Okada, T., Heitz, Ph., Ulrich, J.: Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding. Life Sci. 22, 985–996 (1978 a)
Möhler, H., Okada, T., Enna, S.J.: Benzodiazepine and neurotransmitter receptor binding in rat brain after chronic administration of diazepam or phenobarbital. Brain Res. 156, 391 – 395 (1978 b)
Möhler, H., Polc, P., Cumin, R., Pieri, L., Kettler, R.: Nicotinamide is a brain constituent with benzodiazepine-like actions. Nature 278, 563–565 (1979)
Müller, W., Wollert, U.: Characterization of the binding of benzodiazepines to human serum albumin. Naunyn-Schmiedebergs Arch. Pharmacol. 280, 229–237 (1973)
Müller, W., Wollert, U.: High stereospecificity of the benzodiazepine binding site on human serum albumin. Mol. Pharmacol. 11, 52–60 (1975 a)
Müller, W., Wollert, U.: Benzodiazepines: Specific competitors for the binding of 1-tryptophan to human serum albumin. Naunyn-Schmiedebergs Arch. Pharmacol. 288, 17–27 (1975 b)
Müller, W., Wollert, U.: Interaction of benzodiazepine derivates with bovine serum albumin. J. Biochem. Pharmacol. 25, 141–145 (1976)
Müller, W., Schläfer, U., Wollert, U.: Benzodiazepine receptor binding in rat spinal cord membranes. Neurosci. Lett. 9, 239–243 (1978)
Nahorski, S.R.: Biochemical effects of the anticonvulsants trimethadione, ethosuximide and chlordiazepoxide in rat brain. J. Neurochem. 19, 1937–1946 (1972)
Nakamura, K., Nakamura, K.: Interaction of benzodiazepine drugs with striatal dopaminergic neurons in the brain. Jpn. J. Pharmacol. [Suppl.] 26, 101P (1976)
Nakamura, M., Fukushima, H.: Effect of benzodiazepines on central serotonergic neuron systems. Psychopharmacology 53, 121–126 (1977)
Nelson-Krause, D.C., Howard, B.D.: Release of glycine and gamma aminobutyric acid from synaptosomes prepared from rat central nervous tissue. Fed. Proc. 35, 543 (1976)
Nicoll, R.A.: The effects of anesthetics on synaptic excitation and inhibition in the olfactory bulb. J. Physiol. (Lond.) 223, 803–814 (1972)
Nicoll, R.A.: Presynaptic action of barbiturates in the frog spinal cord. Proc. Natl. Acad. Sci. USA 72, 1460–1463 (1975 a)
Nicoll, R.A.: Pentobarbital: action on frog motoneurons. Brain Res. 96, 119–123 (1975 b)
Nicoll, R.A.: Pentobarbital: Differential postsynaptic actions on sympathetic ganglion cells. Science 199, 451–452 (1978)
Nielsen, M., Braestrup, C., Squires, R.F.: Evidence for a late evolutionary appearance of brain-specific benzodiazepine receptors: an investigation of 18 vertebrate and 5 invertebrate species. Brain Res. 141, 342–346 (1978)
Nielsen, M., Nielsen, E.B., Ellison, G., Braestrup, C.: Modification of dopamine receptors in brain by continuous amphetamine administrations to rats. IInd World Congress of Biol. Psychiatry. Barcelona 1979 to be published, a
Nielsen, M., Gredal, O., Braestrup, C.: Some properties of 3H-diazepam displacing activity from human urine. Life Sci. 25, 679–686 (1979 b)
Olsen, R.W., Lamar, E.E., Bayless, J.D.: Calcium-induced release of γ-aminobutyric acid from synaptosomes: Effects of tranquilizer drugs. J. Neurochem. 28, 299–305 (1977)
Olsen, R.W., Greenlee, D., Ness, P. van, Ticku, M.K.: Studies on the gammaaminobutyric acid receptor/ionophore proteins in mammalian brain. In: Amino acids as neurotransmitter. Fonnum, F. (ed.), pp. 467–486. New York: Plenum 1978 a
Olsen, R.W., Ticku, M.K., Ness, P. van, Greenlee, D.: Effects of drugs on γ-aminobutyric acid receptors, uptake, release and synthesis in vitro. Brain Res. 139, 277–294 (1978 b)
Olsen, R.W., Ticku, M.K., Greenlee, D., Ness, P. van: GABA receptor and ionophore binding sites: Interaction with various drugs. In: GABA-Neurotransmitters. Alfred Benzon Symposium. Krogsgaard-Larsen, P., Scheel-Krüger, J., Kofod, H. (eds.), p. 28. Copenhagen: Munkgsgaard 1978 c
Opmeer, F.A., Gumulka, S.W., Dinnendahl, V., Schönhöfer, P.S.: Effects of stimulatory and depressant drugs on cyclic guanosine 3′,5′-monophosphate and adenosine 3′,5′-monophos-phate levels in mouse brain. Naunyn Schmiedebergs Arch. Pharmacol. 292, 259–265 (1976)
Ostrovskaya, R.U., Molodavkin, G.M.: A study of the GABA-ergic action mechanism of diazepam on the cortical neurons (in Russian). Byul. Eksp. Bil. Med. 82, 1073–1076 (1976)
Ostrovskaya, R.U., Voronina, T.A.: Antagonistic effects of bicuculline and thiosemicarbazide on diazepam tranquilizing action (in Russian). Byul. Eksp. Biol. Med. 83, 293–295 (1977)
Paul, S.M., Skolnick, P.: Rapid changes in brain benzodiazepine receptors after experimental seizures. Science 202, 892–894 (1978)
Pericic, D., Walters, J.R., Chase, T.N.: Effects of diazepam and pentobarbital on amino-oxyacetic acid-induced accumulation of GABA. J. Neurochem. 29, 839–846 (1977)
Persson, T., Waldeck, B.: A reduced rate of turnover of brain noradrenaline during pentobarbitone anaesthesia. J. Pharm. Pharmacol. 23, 377–378 (1971)
Pieri, L., Haefely, W.: The effect of diphenylhydantoin, diazepam and clonazepam on the activity of purkinje cells in the rat cerebellum. Naunyn Schmiedebergs Arch. Pharmacol. 296, 1–4 (1976)
Pletscher, A.: Biochemistry and psychosomatic medicine: The effects of psychotropic drugs on neurohumoral transmitters. In: Psychotropic drugs in internal medicine. Pletscher, A., Marino, A., Pinkerton, P. (eds.), pp. 1–15. Amsterdam: Excerpta Medica 1969
Polc, P., Möhler, H., Haefely, W.: The effect of diazepam on spinal cord activities, possile sites and mechanisms of action. Naunyn Schmiedebergs Arch. Pharmacol. 284, 319–337 (1974)
Polc, P., Haefely, W.: Effects of two benzodiazepines, phenobarbitone, and baclofen on synaptic transmission in the cat cuneate nucleus. Naunyn Schmiedebergs Arch. Pharmacol. 294, 121–131 (1976)
Polzin, R., Barnes, C.D.: The effect of diazepam and Picrotoxin on brainstem evoked dorsal root potentials. Neuropharmacology 15, 133–137 (1976)
Pugsley, T.A., Lippmann, W.: Effects of pyrroxan and chlordiazepoxide on biogenic amine metabolism in the rat brain. Psychopharmacology 50, 113–118 (1976)
Raabe, W., Ayala, G.F.: Diphenylhydantoin increases cortical postsynaptic inhibition. Brain Res. 105, 597–601 (1976)
Raff, M.: Self regulation of membrane receptors. Nature 259, 265–266 (1976)
Randall, L.O., Schallek, W., Sternbach, L.H., Ning, R.Y.: Chemistry and pharmacology of the 1,4-benzodiazepines. In: Psychoharmacological agents. Gordon, M. (ed.), Vol. 3, pp. 175 – 281. New York: Academic Press 1974
Rastogi, R.B., Agarwal, R.A., Lapierre, Y.D., Singhai, R.L.: Effects of acute diazepam and clo-bazam on spontaneous locomotor activity and central amino metabolism in rats. Eur. J. Pharmacol. 43, 91–98 (1977)
Reisine, T.D., Wastek, G.J., Yamamura, H.I.: Alterations in benzodiazepine binding sites in Huntington’s disease. Pharmacologist 20, 240 (1978)
Rutishauser, M.: Beeinflussung des Kohlenhydratstoffwechsels des Rattenhirns durch Psychopharmaka mit sedativer Wirkung. Naunyn Schmiedebergs Arch. Pharmacol. 245, 396–413 (1963)
Saad, S.F.: Effect of diazepam on γ-aminobutyric acid (GABA) content of mouse brain. J. Pharm. Pharmacol. 24, 839–840 (1972)
Saad, S.F., El Masry, A.M., Scott, P.M.: Influence of certain anticonvulsants on the concentration of γ-aminobutyric acid in the cerebral hemispheres of mice. Eur. J. Pharmacol. 17, 386–392 (1972)
Sawaya, M.C., Horton, R.W., Meldrum, B.S.: Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA. Epilepsia 16, 649–655 (1975)
Schaffner, R., Haefely, W.: The effects of diazepam and bicuculline on the striato-nigral evoked potential. Experientia 31, 732 (1975)
Scheel-Krüger, J., Arnt, J., Braestrup, C., Christensen, V., Magelund, G.: Development of new animal models for GABA-ergic actions using muscimol as a tool. In: GABA-Neurotrans-mitters. The Alfred Benzon Symposium. Kofod, H., Krogsgaard-Larsen, P., Scheel-Krüger, J. (eds.), pp. 447–464. Copenhagen: Munksgaard 1978
Schlosser, W.: Action of diazepam on the spinal cord. Arch. Int. Pharmacodyn. Ther. 194, 93–102 (1971)
Schmidt, R.F., Vogel, M.E., Zimmermann, M.: Die Wirkung von Diazepam auf die präsynaptische Hemmung und andere Rückenmarksreflexe. Naunyn Schmiedebergs Arch. Pharmacol. 258, 69–82 (1967)
Seeman, P., Chau-Wong, M., Tedesco, J., Wong, K.: Brain receptors for antipsychotic drugs and dopamine: Direct binding assays. Proc. Natl. Acad. Sci. USA 72, 4376–4380 (1975)
Sethy, V.H.: Effect of hypnotic and anxiolytic agents on regional concentration of acetylcholine in rat brain. Naunyn Schmidebergs Arch. Pharmacol. 301, 157–161 (1978)
Setoguchi, M., Takehara, S., Nakajima, A., Tsumagari, T., Takigawa, Y.: Effects of 6-(o-Chlorophenyl)-8-ethyl-l-methyl-4H-s-triazolo [3,4-c]thieno [2,3-e] [l,4]diazepine (Y-7,131) on the metabolism of biogenic amines in brain. Arzneim. Forsch. 28, 1165–1173 (1978)
Sharman, D.F.: Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br. J. Pharmacol. 28, 153–163 (1966)
Shekoldina, T.G., Vatolkina, O.E., Libinzon, R.E.: Effect of psychotropic preparations on the activity of cAMP phosphodiesterase in brain cortex (in Russian). Vopr. Med. Khim. 24, 166–169 (1978)
Shibuya, T.: Effects of benzodiazepines on brain monoamines. Jpn. J. Pharmacol. [Suppl.] 26, 102P (1976)
Skolnick, P., Marangos, P.J., Goodwin, P.K., Edwards, M., Paul, S.: Identification of inosine and hypoxanthine as endogenous inhibitors of 3H diazepam in the central nervous system. Life Sci. 23, 1473–1480 (1978)
Soubrié, P., Simon, P., Boissier, J.R.: Antagonism of diazepam against central anticholinergic drug-induced hyperactivity in mice: involvement of a GABA mechanism. Neuropharmacology 15, 773–776 (1976)
Speth, R.C., Wastek, G.J., Johnson, P.C., Yamamura, H.I.: Benzodiazepine binding in human brain: Characterization using 3H flunitrazepam. Life Sci. 22, 859–866 (1978)
Squires, R.F., Braestrup, C.: Benzodiazepine receptors in rat brain. Nature 266, 732–734 (1977)
Squires, R., Naquet, R., Riche, D., Braestrup, C.: Increased thermolability of benzodiazepine receptors in cerebral cortex of a baboon with spontaneous seizures. Epilepsia 20, 215–221, (1979 a)
Squires, R.F., Beer, B., Benson, D.I., Coupet, J., Kiepner, CA., Lippa, A.S., Myers, V.: Some evidence for two or more brain-specific benzodiazepine receptors. Pharmacol. Biochem. Behav. 10, 825–830 (1979 b)
Stein, L. Wise, C.D., Berger, B.D.: Antianxiety action of benzodiazepines. Drecrease in activity of serotonin neurons in the punishment system. In: The Benzodiazepines. Garattini, S., Mussini, E., Randall, L.O. (eds.), 299–326. New York: Raven 1973
Stein, L., Wise, C.D., Belluzzi, J.D.: Effects of benzodiazepines on central serotonergic mechanisms. In: Mechanism of action of benzodiazepines. Costa, E., Greengard, P. (eds.), pp. 29–44. New York: Raven 1975
Stein, L., Beluzzi, J.D., Wise, C.D.: Benzodiazepines: Behavioral and neurochemical mechanism. Am J. Psychiatry 134, 665–669 (1977)
Steiner, F.A., Felix, D.: Antagonistic effects of GABA and benzodiazepines on vestibular and cerebellar neurones. Nature 260, 346–347 (1976)
Stone, W.E., Javid, M.J.: Benzodiazepines and phenobarbital as antagonists of dissimilar chemical convulsants. Epilepsia 19, 361–368 (1978)
Stratten, W.P., Barnes, C.D.: Diazepam and presynaptic inhibition. Neuropharmacology 10, 685–696 (1971)
Sullivan, J.W., Sepinwall, J., Cook, L.: Anticonflict evaluation of muscimol, a GABA receptor agonist, alone and in combination with diazepam. Faseb 1978
Syapin, P.J., Skolnick, P.: Characterization of benzodiazepine binding sites in cultured cells of neural origin. J. Neurochem. 32, 1047–1051 (1979)
Tallman, J.F., Thomas, J.W., Gallager, D.W.: GAB Aergic modulation of benzodiazepine binding site sensitivity. Nature 274, 383–384 (1978)
Tarver, J., Bautz, G., Horst, W.D.: A new method for the determination of γ-aminobutyric acid (GABA) in brain. Fed. Proc. 34 (1975)
Tata, J.R.: Hormonal regulation of hormone receptors. Nature 257, 740–741 (1975)
Taylor, K.M., Laverty, R.: The effect of chlordiazepoxide, diazepam and nitrazepam on catecholamine metabolism in regions of the rat brain. Eur. J. Pharmacol. 8, 296–301 (1969)
Taylor, K.M., Laverty, R.: The interaction of chlordiazepoxide, diazepam, and nitrazepam with catecholamine and histamine in regions of the rat brain. In: The Benzodiazepines. Garattini, S., Mussini, E., Randall, L.O. (eds.), pp. 191–202. New York: Raven 1973
Thiebot, M.H., Jobert, A., Soubrie, P.: Effects compares du muscimol et du diazepam sur les inhibitions du comportements induite chez le rat par la nouveaute la punition et le nonrein-forcement. Psychopharmacology 61, 85–89 (1979)
Toffano, G., Guidotti, A., Costa, E.: Purification of an endogenous protein inhibitor of the high affinity binding of γ-aminobutyric acid to synaptic membranes of rat brain. Proc. Natl. Acad. Sci. USA 75, 4024–4028 (1978)
Tonkopy, V.D., Sofronov, G.A., Alexandriiskaya, I.E., Brestkina, L.M.: Study of the mechanism of diazepam influence on acetylcholine level in the mouse brain (in Russian). Byul. Eksp. Biol. Med. 86, 38–40 (1978)
Tsuchiya, T., Fukushima, H.: Effects of benzodiazepines and pentobarbitone on the GABA-ergic recurrent inhibition of hippocampal neurons. Eur. J. Pharmacol. 48, 421–424 (1978)
Volicer, L., Puri, S.K., Choima, P.: Cyclic GMP and GABA levels in rat striatum and cerebellum during morphine withdrawal: Effect of apomorphine. Neuropharmacology 16, 791 – 794 (1977)
Waddington, J.L.: Behavioral evidence for GAB Aergic activity of the benzodiazepine fluraze-pam. Europ. J. Pharmacol. 51, 417–422 (1978)
Waddington, J.L., Owen, F.: Stereospecific benzodiazepine receptor binding by the en-antiomers of oxazepam sodium hemisuccinate. Neuropharmacology 17, 215–216 (1978)
Wastek, G.J., Speth, R.C., Reisine, T.D., Yamamura, H.I.: The effect of γ-aminobutyric acid on 3H-flunitrazepam binding in rat brain. Eur. J. Pharmacol. 50, 445–447 (1978)
Westerink, B.H.C., Lejeune, B., Korf, J., Praag, H.M. van: On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs. Eur. J. Pharmacol. 42, 179–190 (1977)
Williams, M., Risley, E.A.: Enhancement of the binding of 3H-diazepam to rat brain membranes in vitro by SQ 20,009 a novel anxiolytic, γ-aminobutyric acid (GABA) and muscimol. Life Sci., 24, 833–842 (1979)
Wise, D.C., Berger, B.D., Stein, L.: Benzodiazepines: Anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 177, 180–183 (1972)
Wolf, P., Haas, H.L.: Effects of diazepines and barbiturates on hippocampal recurrent inhibition. Naunyn-Schmidebergs Arch. Pharmacol. 299, 211–218 (1977)
Wood, J.D., Peesker, S.J., Gorecki, D.K.J., Tsui, D.: Effect of L-cycloserine on brain GABA metabolism. Can. J. Physiol. Pharmacol. 56, 62–68 (1978)
Yamamura, H.I., Snyder, S.H.: Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. USA 71, 1725–1729 (1974)
Yamamura, H.I., Speth, R.C., Reisine, T.D., Wastek, G.J., Chen, F.M., Kobayashi, R.M.: Biochemical characterization of 3H-flunitrazepam binding to benzodiazepine receptors in the rat brain. 7th Intern. Congr. Pharmacol., Paris 1978 a
Yamamura, H.I., Enna, S.J., Kuhar, M.J.: Neurotransmitter receptor binding. New York: Raven 1978 b
Young, A.B., Zukin, S.R., Snyder, S.H.: Interaction of benzodiazepines with central nervous glycine receptors: Possible mechanism of action. Proc. Natl. Acad. Sci. USA 6, 2246–2250 (1974)
Zakusov, V.V., Ostrovskaya, R.U., Kozhechkin, S.N., Markovich, V.V., Molodavkin, G.M., Voronina, T.A.: Further evidence for GABA-ergic mechanisms in the action of benzodiazepines. Arch. Int. Pharmacodyn. Ther. 229, 313–326 (1977)
Zsilla, G., Cheney, D.L., Costa, E.: Regional changes in the rate of turnover of acetylcholine in rat brain following diazepam or muscimol. Naunyn-Schmiedebergs Arch. Pharmacol. 294, 251–255 (1976)
Zukin, S.R., Young, A.B., Snyder, S.H.: Gamma-aminobutyric acid binding to receptor sites in the rat central nevous system. Proc. Natl. Acad. Sci. USA 71, 4802–4807 (1974)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braestrup, C. (1981). Biochemical Effects of Anxiolytics. In: Hoffmeister, F., Stille, G. (eds) Psychotropic Agents. Handbook of Experimental Pharmacology, vol 55 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67767-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-67767-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67769-4
Online ISBN: 978-3-642-67767-0
eBook Packages: Springer Book Archive